Improve Medical released its performance for the first three quarters, with a net profit attributable to the parent company of 24.0441 million yuan, an increase of 156.55%

Improve Medical released its Q3 2025 report, with operating revenue for the first three quarters at 349 million yuan, a year-on-year decrease of 17.14%. The net profit attributable to the parent company was 24.0441 million yuan, a year-on-year increase of 156.55%; the net profit excluding non-recurring gains and losses was 30.3577 million yuan, a year-on-year increase of 325.04%. The basic earnings per share were 0.08 yuan